Augmentin is generally the stronger antibiotic. In the most common infections where both drugs are prescribed, Augmentin (amoxicillin-clavulanate) consistently outperforms or matches cefdinir in clinical trials, and major guidelines rank it higher for ear infections, sinus infections, and several other conditions. That said, “stronger” depends on the specific infection being treated, and there are situations where cefdinir is the more practical choice.
What the Clinical Evidence Shows
The clearest head-to-head comparison comes from a study of children with ear infections published in the National Institutes of Health database. High-dose Augmentin achieved an 86.5% clinical cure rate compared to 71% for cefdinir, a statistically significant difference. That 15-percentage-point gap is substantial in antibiotic research, where many competing drugs perform within a few points of each other.
A separate trial using standard-dose Augmentin found more comparable results: 86% cure for Augmentin versus about 80 to 83% for cefdinir, depending on whether cefdinir was given once or twice daily. The takeaway is that Augmentin tends to perform at or near the top in these matchups, while cefdinir lands somewhat lower, especially when higher doses of Augmentin are used.
Why Guidelines Favor Augmentin
For bacterial sinus infections in adults, the Infectious Diseases Society of America recommends Augmentin as the first-choice antibiotic. Cefdinir is not listed as a preferred option. For ear infections in children, international guidelines position plain amoxicillin as the first-line drug, with Augmentin reserved as the step-up choice when amoxicillin alone fails or when a child has risk factors like immune deficiency. Cefdinir and other cephalosporins sit further down the list.
This hierarchy exists largely because of how each drug handles resistant bacteria. Many common bacteria produce enzymes called beta-lactamases that break down basic penicillin-type antibiotics. Augmentin solves this problem by pairing amoxicillin with clavulanate, a compound that blocks those enzymes and lets the amoxicillin do its job. Cefdinir, a third-generation cephalosporin, has some natural resistance to these enzymes built into its chemical structure, but in practice this appears to be less effective than Augmentin’s approach for the respiratory and ear infections where both drugs are commonly prescribed.
Where Cefdinir Has Advantages
Cefdinir’s biggest practical advantage is tolerability. Augmentin is notorious for causing diarrhea and stomach upset. The clavulanate component that makes Augmentin effective against resistant bacteria is also the ingredient most responsible for GI side effects. Many patients, particularly young children, struggle to complete a full course of Augmentin because of persistent loose stools or stomach pain.
Cefdinir also offers simpler dosing. It can be taken once or twice daily, while Augmentin typically requires two or three doses per day. For parents giving antibiotics to a reluctant toddler, fewer daily doses can make the difference between finishing the full course and missing doses. An antibiotic that works slightly less well on paper but actually gets taken as prescribed may perform better in real life than one with higher cure rates in controlled trials.
One quirk worth knowing: cefdinir can turn stools a reddish or maroon color when taken alongside iron, including iron-fortified infant formula. This happens because cefdinir combines with iron to form a harmless colored compound in the gut. It looks alarming but is not dangerous.
For Skin Infections, Different Rules Apply
Skin and soft tissue infections shift the comparison somewhat. Treatment guidelines from UCSF list Augmentin as a recommended oral option for skin infections, particularly when the bacteria involved might include types that produce beta-lactamases. Cefdinir is not prominently featured in major skin infection guidelines. For straightforward cellulitis or infected wounds where broader coverage is needed, Augmentin is the more common choice.
Which One Your Doctor Picks and Why
If your doctor prescribed cefdinir instead of Augmentin, it doesn’t necessarily mean you’re getting a weaker treatment. The choice often reflects your specific situation. Cefdinir is a reasonable pick for mild to moderate infections, for patients who’ve had stomach problems with Augmentin in the past, or for anyone with a history of allergic reactions to penicillin-type drugs (though cross-reactivity between penicillins and cephalosporins is low, some doctors prefer the cephalosporin as a precaution).
Augmentin tends to be chosen when the infection is more severe, when first-line treatment has already failed, or when the bacteria involved are likely to be resistant. It’s also the go-to escalation drug: if you started on amoxicillin or cefdinir and aren’t improving after two to three days, Augmentin is often the next step up.
The bottom line is that Augmentin is the more potent option for most of the infections where these two drugs overlap, with cure rates running 5 to 15 percentage points higher depending on the study. Cefdinir is easier on the stomach and simpler to take, which makes it a useful alternative when tolerability or compliance is a concern.